100 related articles for article (PubMed ID: 9747183)
1. Biotransformation and toxicity of the lipoxygenase inhibitor 2-hydroxy-5-methyllaurophenone oxime (FLM 5011) on Hep G2 cells.
Mühlenfeld K; Langner A
Arch Pharm (Weinheim); 1998; 331(7-8):259-61. PubMed ID: 9747183
[TBL] [Abstract][Full Text] [Related]
2. [Biotransformation of the lipoxygenase inhibitor 2-hydroxy-5-methyl-laurophenone-oxime (FLM 5011)].
Langner A; Rentsch C; Nerlich C; Rittner I; Kühn H; Schewe T; Franke P
Pharmazie; 1996 Jun; 51(6):403-9. PubMed ID: 8767850
[TBL] [Abstract][Full Text] [Related]
3. Antiinflammatory effect of a lipoxygenase inhibitor (FLM 5011) in severe active myocarditis.
Geissler W; Förster A; Schewe T; Rapoport SM; Slapke J; Meyer R; Romaniuk P; Reisinger I
Biomed Biochim Acta; 1988; 47(10-11):S311-4. PubMed ID: 3150273
[TBL] [Abstract][Full Text] [Related]
4. [Improvement of the absorption of the active substance 2'-hydroxy-5'-methyllaurophenoxamine (FLM 5011) with prodrugs and preparations].
Tscheuschner C; Neubert R; Fürst W; Lücke L; Fries G
Pharmazie; 1993 Sep; 48(9):681-4. PubMed ID: 8234402
[TBL] [Abstract][Full Text] [Related]
5. The protective effect of lipoxygenase inhibitor FLM 5011 on mitochondria ultrastructure of ischemic and reperfused cardiomyocytes.
Fitzl G; Winkler D; Wassilev G; Welt K
Exp Toxicol Pathol; 1999 May; 51(3):245-53. PubMed ID: 10334466
[TBL] [Abstract][Full Text] [Related]
6. Lipoxygenase inhibitor FLM 5011, an effective protectant of myocardial microvessels against ischemia-reperfusion injury? An ultrastructural-morphometric study.
Welt K; Fitzl G; Mark B
Exp Toxicol Pathol; 2000 Mar; 52(1):27-36. PubMed ID: 10779150
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lipoxygenase (LOX) or of cyclooxygenase (COX) improves survival of rats in endotoxin shock.
Schaper U; Lueddeckens G; Förster W; Scheuch DW
Biomed Biochim Acta; 1988; 47(10-11):S282-5. PubMed ID: 3150270
[TBL] [Abstract][Full Text] [Related]
8. Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver.
Nyberg SL; Remmel RP; Mann HJ; Peshwa MV; Hu WS; Cerra FB
Ann Surg; 1994 Jul; 220(1):59-67. PubMed ID: 8024360
[TBL] [Abstract][Full Text] [Related]
9. Keto- and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in Hep G2 cells via a caspase-8 dependent pathway.
Liu JJ; Nilsson A; Oredsson S; Badmaev V; Duan RD
Int J Mol Med; 2002 Oct; 10(4):501-5. PubMed ID: 12239601
[TBL] [Abstract][Full Text] [Related]
10. Response of the human hepatic tissue cultures Hep-G2 and WRL-68 to cocaine.
Falk PM; Sabater RT; Carballo DD
J Pharmacol Toxicol Methods; 1995 Apr; 33(2):113-20. PubMed ID: 7766918
[TBL] [Abstract][Full Text] [Related]
11. Mutagenic activation of aromatic amines by a human hepatoma cell (Hep G2) supernatant tested by means of Salmonella typhimurium strains with different acetyltransferase activities.
Duverger-van Bogaert M; Dierickx PJ; Crutzen MC
Mutat Res; 1995 Dec; 335(3):219-27. PubMed ID: 8524336
[TBL] [Abstract][Full Text] [Related]
12. Effect of eugenol on the genotoxicity of established mutagens in the liver.
Rompelberg CJ; Evertz SJ; Bruijntjes-Rozier GC; van den Heuvel PD; Verhagen H
Food Chem Toxicol; 1996 Jan; 34(1):33-42. PubMed ID: 8603795
[TBL] [Abstract][Full Text] [Related]
13. Bioanalysis of syn dimeric HIV-1 protease inhibitor N-benzyl 4-aryl-1,4-dihydropyridine H19: metabolic and cytotoxic properties in Hep G2 cells.
Hilgeroth A; Langner A
Arch Pharm (Weinheim); 2000 Jun; 333(6):195-7. PubMed ID: 10909192
[TBL] [Abstract][Full Text] [Related]
14. Indirubin-3-monooxime induced cell cycle arrest and apoptosis in Hep-2 human laryngeal carcinoma cells.
Kameswaran TR; Ramanibai R
Biomed Pharmacother; 2009 Feb; 63(2):146-54. PubMed ID: 18450412
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity and apoptosis produced by cytochrome P450 2E1 in Hep G2 cells.
Chen Q; Cederbaum AI
Mol Pharmacol; 1998 Apr; 53(4):638-48. PubMed ID: 9547353
[TBL] [Abstract][Full Text] [Related]
16. [Lipoxygenase inhibitors induce rat hepatocyte apoptosis in primary culture].
Korniĭchuk HM; Makohon NV; Lushnikova IV; Aleksieieva IM
Ukr Biokhim Zh (1999); 2002; 74(1):125-7. PubMed ID: 12199093
[TBL] [Abstract][Full Text] [Related]
17. Sulindac induces apoptosis, inhibits proliferation and activates caspase-3 in Hep G2 cells.
Liu JJ; Wang JY; Hertervig E; Nilsson A; Duan RD
Anticancer Res; 2002; 22(1A):263-6. PubMed ID: 12017300
[TBL] [Abstract][Full Text] [Related]
18. First bioanalytical evaluation of nonpeptidic cage dimeric HIV-1 protease inhibitor N-benzyl 4-aryl-1,4-dihydropyridine H17: biotransformation and toxicity on Hep G2 cells.
Hilgeroth A; Langner A
Arch Pharm (Weinheim); 2000 Jan; 333(1):32-4. PubMed ID: 10675987
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic, Antiproliferative and Apoptotic Effects of Perillyl Alcohol and Its Biotransformation Metabolite on A549 and HepG2 Cancer Cell Lines.
Oturanel CE; Kıran İ; Özşen Ö; Çiftçi GA; Atlı Ö
Anticancer Agents Med Chem; 2017; 17(9):1243-1250. PubMed ID: 28044940
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene and 5-lipoxygenase inhibitor induced variations in thymidine uptake in a human glioma cell line cultured as monolayers or as multicellular spheroids.
Gáti I; Bergström M; Muhr C; Carlsson J
Anticancer Res; 1994; 14(2A):453-9. PubMed ID: 8017847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
